Great Point Partners

Investor type

PE

Founded

2003

AUM

$1 700 M

Location

Greenwich, Connecticut, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America Europe
Investor profile last updated: 16 August, 2026

Profile

Great Point Partners is a private equity firm based in Greenwich, Connecticut, founded in 2003. The firm specializes in investing in the healthcare sector, with a focus on biopharmaceutical supply chains, healthcare IT-enabled services, healthcare services, and medical device contract manufacturing. The team comprises over 30 professionals, including a CEO Advisory Board and a Medical Advisory Board, providing deep industry expertise and strategic guidance.

The firm manages both private equity and hedge fund strategies, with a total AUM of $1.7 billion. Great Point Partners targets lower middle market growth buyouts in private healthcare companies and invests in public life sciences companies through its hedge fund. The firm primarily invests in the United States, Canada, and Western Europe, focusing on sectors like life sciences and healthcare services.

Notable investments by Great Point Partners include Valenz - healthcare management, Corrona - clinical research, CSM - clinical supplies management, Cytovance - biopharmaceutical manufacturing, and Caprion - proteomics services. These investments highlight the firm's commitment to supporting innovation and growth in the healthcare industry.

Industry

Medical Devices Biotechnology Financial Services Fintech Food and Beverage Foodtech Healthcare Services Life Sciences HealthTech Infrastructure Technology

Great Point Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Great Point Partners Private Equity Fund I
Private Equity (PE)
Biotechnology
Financial Services
Fintech
Healthcare Services
Medical Devices
Infrastructure
HealthTech
Series B
North America
$5-10 m
$156 M
November 2003
Great Point Partners Private Equity Fund II
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
Medical Devices
Technology
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$215 M
October 2013
Great Point Partners IV, L.P.
Private Equity (PE)
Healthcare Services
Medical Devices
Technology
HealthTech
Series B
Late Stage (Series C+)
North America
$5-10 m
$1000 M
October 2023

Contacts

Name
Title
Email
avatar
Jeffrey R. Jay, M.D. Founder Managing Partner Co-Portfolio Manager, BMVF
Founder Managing Partner Co-Portfolio Manager, BMVF
j•••@•••
avatar
Harrison Johnson Vice President
Vice President
h•••@•••
Upgrade to see contacts
avatar
rvMPhReJGwLTui6q rvMPhReJGwLTui6q
rvMPhReJGwLTui6q
avatar
rvMPhReJGwLTui6q rvMPhReJGwLTui6q
rvMPhReJGwLTui6q
avatar
rvMPhReJGwLTui6q rvMPhReJGwLTui6q
rvMPhReJGwLTui6q
Investment-team contacts for Great Point Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Great Point Partners

Great Point Partners is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Great Point Partners is located in Greenwich, Connecticut, United States.
Great Point Partners was founded in 2003.
Great Point Partners invests in companies and startups in Medical Devices, Biotechnology, Financial Services, Fintech, Food and Beverage, Foodtech, Healthcare Services, Life Sciences, HealthTech, Infrastructure, Technology.
Great Point Partners invests in companies and startups in North America, Europe.
Great Point Partners invests in companies and startups at Series B, Late Stage (Series C+).
Great Point Partners usually invests $10-50 m on average.
Great Point Partners has around $1 700m assets under management.
Great Point Partners last fund was created/launched in 2023-10-10
Great Point Partners can be reached through its website gppfunds.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Great Point Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Great Point Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.